Emblaveo will be available in the third quarter of 2025 to treat patients with intra-abdominal infections, a common cause of sepsis in the intensive care unit.
Addresses the significant threat of antimicrobial resistance.
The FDA has approved Emblaveo with metronidazole for patients with complicated intra-abdominal infections and limited options.
2d
AbbVie (ABBV) announced the U.S. Food and Drug Administration approval of Emblaveo (aztreonam and avibactam). This marks the first ...
AbbVie said on Friday that the U.S. Food and Drug Administration approved its drug for complicated intra-abdominal infections ...
So, if symptoms or pain occur, you should talk to your doctor about treatment options. For example, painful hernias will typically need surgical repair. Below, learn about common hernia symptoms and ...
Finding it hard to breathe when you lay down is medically called orthopnea. Find a list of potential causes to help narrow ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback